← FDA Drug Approvals (Drugs@FDA)

DAPSONE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SUN PHARMA CANADA · Approved 2017-10-16

Drug application

FDA Application #

ANDA209506

Application type

Abbreviated New Drug Application (Generic)

Brand name

DAPSONE

Generic name

DAPSONE

Active ingredients

DAPSONE

Dosage form

GEL

Route

TOPICAL

Marketing status

Prescription

Sponsor

SUN PHARMA CANADA

Manufacturer

Sun Pharmaceutical Industries, Inc.

First approval

2017-10-16

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown